FR Alert – Covering:02/04/2020

Todays Federal Register

DEPARTMENT OF COMMERCE

Agency Notice
SUMMARY: The Department of Commerce (Commerce) finds that revocation of the countervailing duty (CVD) order on chlorinated isocyanurates from the People’s Republic of China (China) would be likely to lead to the continuation or recurrence of a countervailable subsidy at the levels indicated in the “Final Results of Sunset Review” section of this notice. DATES: Applicable February 4, 2020. FOR FURTHER INFORMATION CONTACT: Nathan James, AD/CVD Operations, Office V, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-5305. SUPPLEMENTARY INFORMATION: Background On November 13, 2014, Commerce published in the Federal Register the CVD order on chlorinated isocyanurates from China.\1\ On October 1, 2019, Commerce published the notice of initiation of the first sunset review of the CVD order on chlorinated isocyanurates from China, pursuant to section 751(c) of the Tariff Act of 1930, [[Page 6143]]
[20-02124][Full Article] [PDF]
Agency Notice
SUMMARY: The Department of Commerce (Commerce) hereby notifies the public and members of the trade community of the implementation of the inspection program established by Section VII.C of the 2019 Agreement Suspending the Antidumping Duty Investigation on Fresh Tomatoes from Mexico (2019 Suspension Agreement). Implementation of the Section VII.C inspection program will begin 60 days from the date of publication of this notice. Beginning 60 days from the date of publication of this notice, certain fresh tomatoes from Mexico shall be subject to a United States Department of Agriculture (USDA) inspection for quality and condition defects. FOR FURTHER INFORMATION CONTACT: Sally C. Gannon or David Cordell at (202) 482-0162 or (202) 482-0408, respectively; Bilateral Agreements Unit, Office of Policy, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230. SUPPLEMENTARY INFORMATION: Background On September 19, 2019, Commerce and signatory producers/exporters accounting for substantially all imports of fresh tomatoes from Mexico signed the 2019 Suspension Agreement.\1\ Section VII.C of the 2019 Suspension Agreement states: “Beginning approximately (and no less
[20-02166][Full Article] [PDF]

DEPARTMENT OF ENERGY

Agency Notice
SUMMARY: The U.S. Department of Energy (DOE) Solar Energy Technologies Office (SETO) is issuing this request for information (RFI) to solicit feedback from industry, academia, research laboratories, government agencies, and other stakeholders. This RFI will inform SETO’s strategic planning on research related to the integration of solar energy resources. Specifically, this RFI will inform SETO’s strategies relating to prediction of solar irradiance reaching the surface of the earth, and power output from solar generation plants, using either photovoltaic (PV) or concentrating solar power (CSP) technologies. Improving solar generation prediction will better inform grid operators as they consider the impacts of solar power variability on grid planning and operations technologies, as well as the owners and operators of utility-scale plants and aggregators of distributed PV systems. DATES: SETO will accept response to the RFI for at least 30 days after February 4, 2020, the date this notice is published. ADDRESSES: Interested parties are to submit comments electronically to: SETO.RFI.SI@ee.doe.gov. Include Prediction of Solar Variability for Better Grid Integration, in the subject of the title. Only electronic responses will be accepted. The complete RFI document DE-FOA-0002284 is located at https://eere-exchange.energy.gov. FOR FURTHER
[20-02123][Full Article] [PDF]
Agency Notice
SUMMARY: On December 6, 2019, the U.S. Department of Energy published a proposal to amend the test procedures for external power supplies. The proposal provided an opportunity for submitting written comments, data, and information by February 4, 2020. On January 21, 2020, DOE received a request from the USB Implementers Forum, Inc. to extend the public comment period by 14 days. DOE has reviewed this request and is granting the 14-day extension. [[Page 6103]] DATES: The comment period for the NOPR published on December 6, 2019 (84 FR 67106) is extended. DOE will accept comments, data, and information regarding this request for information received no later than February 18, 2020. ADDRESSES: Interested persons are encouraged to submit comments using the Federal eRulemaking Portal at http://www.regulations.gov. Follow the instructions for submitting comments. Alternatively, interested persons may submit comments, identified by docket number EERE-2019-BT- TP-2012, by any of the following methods: (1) Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments. (2) Email: EPS2019TP0012@ee.doe.gov. Include the docket number EERE-2019-BT-TP-2012 or regulatory information number (RIN) 1904-AD86
[20-02122][Full Article] [PDF]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency Notice
SUMMARY: The Food and Drug Administration (FDA, the Agency, or we), in collaboration with the Federal Trade Commission (FTC), is announcing a public workshop on March 9, 2020, “FDA/FTC Workshop on a Competitive Marketplace for Biosimilars.” The purpose of the public workshop is to discuss FDA and FTC’s collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading communications about biosimilars, and deter anticompetitive behaviors in the biologic product marketplace. DATES: The public workshop will be held on March 9, 2020, from 9 a.m. to 5 p.m. Persons seeking to speak at the public workshop must register by February 24, 2020. Persons seeking to attend but not speak at the public workshop must register by March 4, 2020. Section III provides attendance and registration information. Electronic or written comments will be accepted until April 9, 2020. ADDRESSES: The public workshop will be held at FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Rm. 1503A), Silver Spring, MD 20993-0002. Entrance for the public workshop participants (non-FDA employees) is through Building 1 where routine security check procedures will be performed. For parking and security information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOak
[20-02101][Full Article] [PDF]

DEPARTMENT OF HOMELAND SECURITY

Agency Notice
SUMMARY: This document announces the decision of the Secretary of the Department of Homeland Security (DHS) to direct all flights to the United States carrying persons who have recently traveled from, or were otherwise present within, the People’s Republic of China to arrive at one of the United States airports where the United States Government is focusing public health resources to implement enhanced screening procedures. For purposes of this document, a person has recently traveled from the People’s Republic of China if that person has departed from, or was otherwise present within, the People’s Republic of China (excluding the special autonomous regions of Hong Kong and Macau) within 14 days of the date of the person’s entry or attempted entry into the United States. Also, for purposes of this document, crew, and flights carrying only cargo (i.e., no passengers or non- crew), are excluded from the measures herein. DATES: The arrival restrictions begin at 5 p.m. EST on Sunday, February 2, 2020; and continue until cancelled or modified by the Secretary of DHS and notification is published in the Federal Register of such cancellation or modification. FOR FURTHER INFORMATION CONTACT: Alyce Modesto, Office of Field Operations, 202-344-3788. SUPPLEMENTARY INFORMATION:
[20-02318][Full Article] [PDF]

DEPARTMENT OF JUSTICE

Agency Notice
[Notices] [Page 6222] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2020-02087] ———————————————————————– DEPARTMENT OF JUSTICE Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993–Medical CBRN Defense Notice is hereby given that, on January 16, 2020, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (“the Act”), Medical CBRN Defense Consortium (“MCDC”) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances.
[20-02087][Full Article] [PDF]

INTERNATIONAL TRADE COMMISSION

Agency Notice
SUMMARY: The Department of Commerce (Commerce) is modifying two regulations pertaining to the determination of benefit and specificity in countervailing duty proceedings. These modifications clarify how Commerce will determine the existence of a benefit when examining a subsidy resulting from currency undervaluation and clarify that companies in the traded goods sector of the economy can constitute a group of enterprises for purposes of determining whether a subsidy is specific. DATES: Effective date: April 6, 2020. Applicability date: This rule will apply to all segments of proceedings initiated on or after April 6, 2020. FOR FOR FURTHER INFORMATION CONTACT: Gregory Campbell at (202) 482-2239 or Matthew Walden at (202) 482-2963. SUPPLEMENTARY INFORMATION: Background On May 28, 2019, we published the Modification of Regulations Regarding Benefit and Specificity in Countervailing Duty Proceedings; Proposed Rule and Request for Comments.\1\ In the proposed rule, we explained that neither the Tariff Act of 1930, as amended (the Act) nor 
[20-02097][Full Article] [PDF]